I
IOVA icon

InceptionR’s Iovance Biotherapeutics IOVA Stock Holding History

InceptionR’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
+34,371
New +$131K 0.04% 614
2025
Q3 		– Sell
-12,909
Closed -$22.2K – 809
2025
Q2 		$22.2K Buy
+12,909
New +$32.1K 0.01% 627
2024
Q4 		– Sell
-10,040
Closed -$94.3K – 741
2024
Q3 		$94.3K Buy
+10,040
New +$95.1K 0.02% 597
2024
Q1 		– Sell
-13,266
Closed -$108K – 646
2023
Q4 		$108K Buy
+13,266
New +$69.4K 0.08% 329

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

InceptionR's IOVA Position: Q2 2026 in Review

InceptionR opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 34,371 shares worth $143K. The stake represents 0.04% of the portfolio and ranks #614 among its holdings. This is a return to the name: InceptionR previously reported a position in IOVA as recently as Q2 2025.

InceptionR first reported a position in IOVA in Q4 2023 and has held it in 4 quarters since. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • InceptionR held 34,371 shares of Iovance Biotherapeutics worth $143K as of Q2 2026.
  • Iovance Biotherapeutics was a new InceptionR position in Q2 2026.
  • Iovance Biotherapeutics made up 0.04% of InceptionR's portfolio in Q2 2026, its #614 holding.
  • InceptionR first reported a position in Iovance Biotherapeutics in Q4 2023 and has held it in 4 quarters since.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.